Leading the way to safer medication
 Crosscheck  Recommender

Butamirate

Brand names: BUVASTIN SINECOD

Therapeutic Indications

Butamirate is indicated for:

Dry cough

Irrespective of gender only Children (1 year - 12 years old)

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Oral - 7.5-15mg τρεις φορές την ημέρα

Dry cough

Irrespective of gender only Adults (18 years old or older)

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Oral - 22.5 mg four times a day

Dry cough

Irrespective of gender only Adolescents (12 years - 18 years old)

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Oral - 22.5mg three times a day

Contraindications

Active ingredient Butamirate is contraindicated in the following cases: